Atherogenesis in renal patients: a model of vascular disease?

Area of Science:

• Nephrology and Cardiovascular Medicine
• Atherosclerosis Pathogenesis
• Renal Disease Complications

Background:

• Chronic kidney disease (CKD) patients face a 20-fold higher risk of cardiovascular death due to accelerated atherosclerosis.
• Atherosclerosis complications are the primary cause of mortality and reduced life expectancy in individuals with kidney failure.
• Established risk factors like hypertension, diabetes, and dyslipidemia contribute to this phenomenon.

Purpose of the Study:

• To review the intricate relationship between renal and non-renal atherosclerosis.
• To explore the shared pathogenesis, risk factors, and clinical events.
• To understand how these factors interact with available treatment options.

Main Methods:

• Literature review focusing on the pathogenesis of atherosclerosis in CKD patients.
• Analysis of established and emerging risk factors for renal and non-renal atherosclerosis.
• Examination of clinical events and treatment implications in the context of CKD.

Main Results:

• CKD is associated with accelerated atherosclerosis, with established risk factors playing a significant role.
• Emerging risk factors include inflammation, specific lipid disorders, vascular calcification, and oxidative stress.
• CKD may serve as a model for studying atherogenesis, offering insights into the non-renal population.

Conclusions:

• The precise mechanisms of atherosclerosis in kidney failure remain under investigation.
• Investigating renal atherogenesis can enhance understanding of atherosclerosis in the general population.
• Advanced stages of CKD are comparable to coronary heart disease in terms of risk.